Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ABACAVIR | 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-28 | 8 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-01-03 | 2018-01-18 | 34826 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2018-11-16 | 2019-01-23 | 67019 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2022-04-06 | 2022-08-11 | 157992 |
APO-ABACAVIR | 300MG | TABLET | Resolved | 2023-07-13 | 2023-08-12 | 198465 |
APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-05-16 | 2017-07-20 | 10439 |
APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2017-11-01 | 2018-02-17 | 27770 |
APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2020-11-04 | 2020-12-31 | 127762 |
APO TRIAZIDE | 50MG 25MG | TABLET | Resolved | 2021-03-05 | 2021-06-14 | 135181 |
APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2023-11-06 | 2023-11-10 | 209357 |
APO TRIAZIDE | 25MG 50MG | TABLET | Resolved | 2024-03-08 | 2024-04-05 | 221702 |
APO-PROPRANOLOL | 80MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18910 |
APO-PROPRANOLOL | 40MG | TABLET | Resolved | 2017-08-11 | 2020-02-13 | 18769 |
APO-PROPRANOLOL | 120MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18951 |
APO-PROPRANOLOL | 10MG | TABLET | Actual shortage | 2017-08-11 | 2017-10-05 | 18913 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-04-19 | 2017-05-01 | 7234 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-06-27 | 2017-07-28 | 14003 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-10-23 | 2017-11-20 | 26629 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2020-05-08 | 2020-06-02 | 114315 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2022-01-21 | 2022-01-22 | 153285 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |